Steve Bowman, PhD is a Director at Shire who joined the company in 2015 as the Leader of the newly-formed Device Center of Excellence, in recognition of the increasing importance of devices and combination products to Shire’s continued growth. He’s currently the Device Program Lead for two high-value rare disease products (Natpar/Natpara and Gattex/Revestive), responsible for all new global device development activities. Prior to joining Shire Steve was the Sr. Director of Sports Medicine R&D for Smith & Nephew, responsible for all global development of surgical implants and instruments for arthroscopic knee, shoulder and hip repair. He started his career at Johnson & Johnson, with multiple roles of increasing responsibility in R&D, Biologics Manufacturing, Project Management and Alliance Management. Steve earned a BS in Mechanical Engineering from Columbia University, and a PhD in Medical Engineering and Medical Physics from the Harvard - MIT Program of Health Sciences and Technology.